Disease: Cancer, thyroid

KEYTRUDA

Pembrolizumab 25mg/mL; per vial; soln for IV infusion after dilution; preservative-free.

RETEVMO

Selpercatinib 40mg, 80mg; hard gelatin caps.

GAVRETO

Pralsetinib 100mg; caps.

ROZLYTREK

Entrectinib 100mg, 200mg; caps.

VITRAKVI

Larotrectinib 25mg, 100mg; caps.

TIROSINT-SOL

Levothyroxine sodium 13mcg/mL, 25mcg/mL, 50mcg/mL, 75mcg/mL, 88mcg/mL, 100mcg/mL, 112mcg/mL, 125mcg/mL, 137mcg/mL, 150mcg/mL, 175mcg/mL, 200mcg/mL; oral soln; contains glycerol.

LENVIMA

Lenvatinib 4mg, 10mg; caps.

TAFINLAR

Dabrafenib 50mg, 75mg; caps.

MEKINIST

Trametinib 0.5mg, 2mg; tabs.